Crispina Calsada

Insider Reports History

Identity
Location
San Diego, CA
SEC record
Reporting signature
/s/ Christopher Aker, Attorney-in-Fact
SEC evidence
Transaction evidence
Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Holdings reported by Crispina Calsada:

Form 4 holding Chief Financial Officer

Regulus Therapeutics Inc.

Security class
Stock Option (Right to Buy)
Shares / value
562,500
Estimated value
Report date
30 Jan 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Crispina Calsada

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .